Business Wire - ASCEND Study to Evaluate the Effectiveness of TYSABRI® (natalizumab) as a Treatment for Secondary-Progressive Multiple Sclerosis
Posted by admin / Under Multiple SclerosisJanuary 26, 2012 --
Published on Sunday 5th of February 2012 05:15:37 AM
Read more...







Share this!